发明名称 Determining the transforming capability of agents
摘要 The invention related to activation of apoptin-induced apoptosis by different cell-transforming agents in normal and or cancer-prone cells. Apoptin, also called VP3, is a viral protein derived from the Chicken anemia virus. Also the invention related to preventive anti-tumor therapies of normal and/or cancer-prone cells. Treatment of normal and/or cancer prone cells with tumor-inducing agents will activate apoptin-induced apoptosis, resulting in the elimination of potential tumor cells. Also the invention relates to diagnosis of cancer agents. Agents with tumor activity can be examined by expressing them in normal cells and analyzing their capability of enabling apoptin-induced apoptosis.
申请公布号 AU8752998(A) 申请公布日期 1999.03.01
申请号 AU19980087529 申请日期 1998.08.11
申请人 LEADD B.V. 发明人 MATHIEU HUBERTUS MARIA NOTEBORN
分类号 C12Q1/00;G01N33/15;G01N33/50;G01N33/574;G01N33/68 主分类号 C12Q1/00
代理机构 代理人
主权项
地址